Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

This study has been terminated.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University of Kentucky
ClinicalTrials.gov Identifier:
NCT00176241
First received: September 12, 2005
Last updated: January 27, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: November 2009
  Estimated Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)